drug
Migranal
Marketedupdated 3mo agoby Bausch Health US LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(0)
nothing on the calendar yet
Trials studying Migranal
Patent cliff
source: FDA Orange Bookfirst barrier falls
Apr 30, 2028
~1.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (16)
- Oct 12, 2041formulationUS 11744967
- Oct 12, 2041formulationUS 12102754
- Dec 11, 2039formulationUS 10758532
- Dec 11, 2039formulationUS 12263162
- Feb 26, 2039formulationUS 10532049
- Feb 26, 2039formulationUS 11304942
- Feb 26, 2039method-of-use (U-4188)US 11819501
- Feb 26, 2039formulationUS 12533351
- Jan 4, 2039method-of-use (U-3218)US 11185497
- Aug 4, 2037formulationUS 10792253
- Aug 4, 2037formulationUS 11872314
- Nov 5, 2036formulationUS 11266799
- Mar 17, 2033formulationUS 9919117
- Jan 23, 2033formulationUS 10940278
- Dec 25, 2032formulationUS 10507295
- Sep 5, 2032formulationUS 9550036
FDA exclusivities (1)
- Apr 30, 2028NPNP1.7y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 52m ago
Found something off?
comments(0)
5-min edit window · permanent after that